NYSE:EWMedical Equipment
Edwards Lifesciences (NYSE:EW) Removed From Multiple Russell Growth Indexes
Edwards Lifesciences (NYSE:EW) experienced a 7.91% price increase over the last quarter, amidst significant developments. On June 30, 2025, the company was removed from several Russell indices, potentially affecting its visibility among growth-focused funds and possibly influencing institutional investment. However, Edwards Lifesciences bolstered its market position with key product approvals, including Health Canada's approval of its EVOQUE tricuspid valve replacement system and the FDA's...